Selective peroxisome proliferator activated receptor modulators
    3.
    发明申请
    Selective peroxisome proliferator activated receptor modulators 失效
    选择性过氧化物酶体增殖物激活受体调节剂

    公开(公告)号:US20070066683A1

    公开(公告)日:2007-03-22

    申请号:US10596256

    申请日:2004-12-08

    IPC分类号: A61K31/195 C07C237/20

    CPC分类号: C07C235/08 C07C235/20

    摘要: The present invention is directed to a novel compound, its composition and use of a compound having a structural formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

    摘要翻译: 本发明涉及一种新型化合物,其组合物和具有结构式(I)化合物或其药学上可接受的盐,溶剂合物,水合物或立体异构体的组合物和用途,其可用于治疗或预防由过氧化物酶体介导的病症 增殖激活受体(PPAR)如X综合征,II型糖尿病,高血糖症,高脂血症,肥胖症,凝血病,高血压,动脉硬化以及与X和心血管疾病相关的其他疾病。